Inspire Medical Systems, Inc. (NYSE: INSP) is a Healthcare company (Medical - Devices) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
Inspire Medical Systems, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $59.41, Inspire Medical Systems, Inc. trades at 16.8x trailing earnings, 1.9x sales and 2.1x book value, with an EV/EBITDA of 33.8. Over the last twelve months it generated about $893M of revenue and $102M of net income. It runs a gross margin of 86.2%, an operating margin of 1.8% and a net margin of 11.4%. It shows return on equity of 12.5%, return on invested capital of 1.8% and a free cash flow yield of 5.7%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 6.45. Over the past 52 weeks the share price ranged from $38.91 to $147.03, with a beta of 0.65.
Inspire Medical Systems, Inc. does not currently pay a dividend.
29 Wall Street analyst ratings cover the stock: 12 Buy, 16 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.